Follow the Saniona AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Saniona AB has published 17 reports. Market capitalisation: €1.6bn. The latest transaction was filed on 1 September 2026 (Purchase). Among the most active insiders: John Haurum. The full history is openly available.
17
Insider Decl.
n/a
Thresholds
€397,767
14 ops.
Buy Volume
€701,072
3 ops.
Sell Volume
39Σ signal
Buys €397,767€701,072 Sells
Fundamental score
Ranked 34 of 29,053 companies
94.1
score / 100
Value
91
Quality
97
FCF yld12%
Earn yld18%
EV/EBITDA5.1x
ROE41%
Gross mgn99%
Net mgn66%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Saniona AB is a biopharmaceutical company focused on developing treatments for central nervous system disorders and metabolic diseases. It is listed on the XSTO exchange.